Polat, E. Et Al. 2021. Investigation of Anti-Cancer Effects of Enantiomerically Pure (S)-4-Aminoquinazoline Derivatives on Human Liver (HepG2) Cancer Cell Line. 3rd Eurasia Biochemical Approaches & Technologies Congress (3. EBAT) , (Antalya, Turkey), 86.

Polat, E., Karaca, E., Günaydın, Ş., Budak, H., & Çakıcı, M., (2021). Investigation of Anti-Cancer Effects of Enantiomerically Pure (S)-4-Aminoquinazoline Derivatives on Human Liver (HepG2) Cancer Cell Line . 3rd Eurasia Biochemical Approaches & Technologies Congress (3. EBAT) (pp.86). Antalya, Turkey

Polat, Emrah Et Al. "Investigation of Anti-Cancer Effects of Enantiomerically Pure (S)-4-Aminoquinazoline Derivatives on Human Liver (HepG2) Cancer Cell Line," 3rd Eurasia Biochemical Approaches & Technologies Congress (3. EBAT), Antalya, Turkey, 2021

Polat, Emrah Et Al. "Investigation of Anti-Cancer Effects of Enantiomerically Pure (S)-4-Aminoquinazoline Derivatives on Human Liver (HepG2) Cancer Cell Line." 3rd Eurasia Biochemical Approaches & Technologies Congress (3. EBAT) , Antalya, Turkey, pp.86, 2021

Polat, E. Et Al. (2021) . "Investigation of Anti-Cancer Effects of Enantiomerically Pure (S)-4-Aminoquinazoline Derivatives on Human Liver (HepG2) Cancer Cell Line." 3rd Eurasia Biochemical Approaches & Technologies Congress (3. EBAT) , Antalya, Turkey, p.86.

@conferencepaper{conferencepaper, author={Emrah Polat Et Al. }, title={Investigation of Anti-Cancer Effects of Enantiomerically Pure (S)-4-Aminoquinazoline Derivatives on Human Liver (HepG2) Cancer Cell Line}, congress name={3rd Eurasia Biochemical Approaches & Technologies Congress (3. EBAT)}, city={Antalya}, country={Turkey}, year={2021}, pages={86} }